The therapeutic potential of targeting tryptophan catabolism in cancer | British Journal of Cancer
Recombinant Mouse TDO2 His-tag Protein, CF 10001-TD-020: R&D Systems
TDO2 antibody | Anti-TDO2 | stjohnslabs
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma | BMC Cancer | Full Text
TDO2 Antibody (H00006999-B01P): Novus Biologicals
A comprehensive analysis of TDO2 expression in immune cells and characterization of immune cell phenotype in TDO2 knockout mice | SpringerLink
Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities - ScienceDirect
-Immunohistochemistry-NBP2-45995-img0009.jpg "TDO2 Antibody (OTI2A4) (NBP2-45995): Novus Biologicals")
TDO2 Antibody (OTI2A4) (NBP2-45995): Novus Biologicals
Frontiers | TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
TDO2 Antibody (ABIN2782335)
Hormonal regulation of Tdo2 expression. (A) Real-time PCR analysis of... | Download Scientific Diagram
Frontiers | TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
Anti-TDO2 Antibody (CAB13182) | WB
TDO2 antibody (15880-1-AP) | Proteintech
Anti-TDO2 / TDO Antibody (A90128) | Antibodies.com
TDO2 Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech 150 μL; Unconjugated Products | Fisher Scientific
Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway | Cancer Cell International | Full Text
Tryptophan 2,3-dioxygenase - Wikipedia
TDO2 antibody (15880-1-AP) | Proteintech
Molecules | Free Full-Text | Discovery and Characterisation of Dual Inhibitors of Tryptophan 2,3-Dioxygenase (TDO2) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Using Virtual Screening
TDO2 modulated Trp/Kyn metabolism to regulate tumor progression. A 10 5... | Download Scientific Diagram
Anti-TDO2 Antibody (CAB6766) | WB
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer - Pham - 2021 - Cancer Reports - Wiley Online Library
TDO2 Antibody | 137-GWB-MQ206H
Frontiers | Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ
